Busaidy Busaidy NL NL Konda Konda B B Wei Wei L L Wirth Wirth LJ LJ Devine Devine C C Daniels Daniels GA GA Dabrafenib versus dabrafenib + trametinib in BRAF-mutated radioactive iodine refractory differentiated thyroid cancer: results of a randomized, phase 2, open-label multicenter trial Dabrafenib versus dabrafenib + trametinib in BRAF-mutated radioactive iodine refractory differentiated thyroid cancer: results of a randomized, phase 2, open-label multicenter trial Thyroid Thyroid 2022 2022 32 32 1184 1184 92 92 10.1089/thy.2022.0115 10.1089/thy.2022.0115 35658604 35658604. Here, BRAF is linked to differentiated thyroid carcinoma.